• Show All
• A
• B
• C
• D
• E
• F
• G
• H
• I
• J
• K
• L
• M
• N
• O
• P
• Q
• R
• S
• T
• U
• V
• W
• X
• Y
• Z
• Numerically Named Products
• Recently updated
• Recently authorised
• Search

• Home
• Currently authorised products
• Expired products
• Suspended products
• Registered homeopathics
• Refused applications

Expired products

The expired products

Territory	Product name	MA holder	VM number	Authorisation route	Active substances ▲	Expired date
	Lincophar 400 mg/ml Solution for Use in Drinking Water for Chickens	Ecuphar Veterinaria S.L.U.	46037/4004	Mutually Recognised	Lincomycin	12/11/2020
Northern Ireland	AquaVac Vibrio Immersion and Injection	MSD Animal Health UK Limited	01708/4569	Mutually Recognised	Listonella anguillarum	14/05/2024
Northern Ireland	AquaVac Vibrio Oral	MSD Animal Health UK Limited	01708/4570	Mutually Recognised	Listonella anguillarum	15/03/2022
Great Britain	AquaVac Vibrio Oral	MSD Animal Health UK Limited	01708/4570	National	Listonella anguillarum	15/03/2022
Great Britain	AquaVac Vibrio Immersion and Injection	MSD Animal Health UK Limited	01708/4569	National	Listonella anguillarum	14/05/2024
United Kingdom	Louping-Ill Vaccine	MSD Animal Health UK Limited	01708/4555	National	Louping Ill virus	04/06/2020
United Kingdom	Program Tablets 67.8 mg	Elanco Europe Ltd	00879/4018	National	Lufenuron	26/01/2024
United Kingdom	Program Oral Suspension for Large Cats 266 mg	Elanco Europe Ltd	00879/4022	National (Informed Consent)	Lufenuron	03/05/2022
United Kingdom	Program Oral Suspension for Small Cats and Kittens 133 mg	Elanco Europe Ltd	00879/4021	National	Lufenuron	03/05/2022
United Kingdom	Program Tablets 409.8 mg	Elanco Europe Ltd	00879/4020	National	Lufenuron	26/01/2024
United Kingdom	Program Tablets 204.9 mg	Elanco Europe Ltd	00879/4019	National	Lufenuron	26/01/2024
Great Britain	Program Plus Film-coated Tablets 5.75 mg/115 mg	Elanco Europe Ltd	00879/4031	National	Lufenuron Milbemycin Oxime (a3 And A4)	09/01/2023
Great Britain	Program Plus Film-coated Tablets 11.5 mg/230 mg	Elanco Europe Ltd	00879/4028	National	Lufenuron Milbemycin Oxime (a3 And A4)	09/01/2023
Great Britain	Program Plus Film-coated Tablets 23 mg/460 mg	Elanco Europe Ltd	00879/4030	National	Lufenuron Milbemycin Oxime (a3 And A4)	09/01/2023
Northern Ireland	Program Plus Film-coated Tablets 11.5 mg/230 mg	Elanco Europe Ltd	00879/4028	Mutually Recognised	Lufenuron Milbemycin Oxime (a3 And A4)	09/01/2023
Northern Ireland	Program Plus Film-coated Tablets 2.3 mg/46 mg	Elanco Europe Ltd	00879/4029	Mutually Recognised	Lufenuron Milbemycin Oxime (a3 And A4)	09/01/2023
Northern Ireland	Program Plus Film-coated Tablets 23 mg/460 mg	Elanco Europe Ltd	00879/4030	Mutually Recognised	Lufenuron Milbemycin Oxime (a3 And A4)	09/01/2023
Northern Ireland	Program Plus Film-coated Tablets 5.75 mg/115 mg	Elanco Europe Ltd	00879/4031	Mutually Recognised	Lufenuron Milbemycin Oxime (a3 And A4)	09/01/2023
Great Britain	Program Plus Film-coated Tablets 2.3 mg/46 mg	Elanco Europe Ltd	00879/4029	National	Lufenuron Milbemycin Oxime (a3 And A4)	09/01/2023
United Kingdom	Magnidown 25% w/v Solution for Injection	Norbrook Laboratories Limited	02000/4287	National (Informed Consent)	Magnesium Sulphate Heptahydrate	11/07/2022

1. 1
2. 2
3. 3
4. ...
5. 23
6. 24
7. 25
8. 26
9. 27
10. 28
11. 29
12. ...
13. 33
14. 34
15. 35